Achievements in hematology in the twentieth century: an introduction

New approaches to the management of hepatitis and endocrine disorders in Cooley's anemia.

Annals of the New York Academy of Sciences·1998

Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cells.

Oncogene·1998

Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients.

Blood·1998

Expression of the human major vault protein LRP in acute myeloid leukemia.

Experimental hematology·1997

Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients.

British journal of haematology·1997

Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response.

Leukemia·1997

Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.

Seminars in hematology·2026

The current state of cerebral complications of sickle cell disease.

Seminars in hematology·2026

Blood or marrow transplantation and cellular therapies in myeloproliferative neoplasms: A comprehensive review.

Seminars in hematology·2026

The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Seminars in hematology·2026

Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis.

Seminars in hematology·2026

Germline predisposition in myeloproliferative neoplasms.

Seminars in hematology·2026

Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.

Cancer management and research·2026

Clonotypic characterization defines B-cell drivers of clonal expansion and intratumor heterogeneity in IgM monoclonal gammopathies.

HemaSphere·2026

A guide to selecting high-performing antibodies for Syntenin-1 (O00560) for use in western blot, immunoprecipitation, and immunofluorescence.

F1000Research·2026

A guide to selecting high-performing renewable antibodies for KIF5A (Q12840) across western blot, immunoprecipitation, and immunofluorescence.

F1000Research·2026

SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry.

Journal of translational medicine·2026

Beyond the platelet count: A systematic review of artificial intelligence in immune thrombocytopenia.

Blood reviews·2026

Related Experiment Videos

Achievements in hematology in the twentieth century: an introduction

Related Concept Videos

New approaches to the management of hepatitis and endocrine disorders in Cooley's anemia.

Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cells.

Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients.

Expression of the human major vault protein LRP in acute myeloid leukemia.

Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients.

Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response.

Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.

The current state of cerebral complications of sickle cell disease.

Blood or marrow transplantation and cellular therapies in myeloproliferative neoplasms: A comprehensive review.

The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis.

Germline predisposition in myeloproliferative neoplasms.

Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.

Clonotypic characterization defines B-cell drivers of clonal expansion and intratumor heterogeneity in IgM monoclonal gammopathies.

A guide to selecting high-performing antibodies for Syntenin-1 (O00560) for use in western blot, immunoprecipitation, and immunofluorescence.

A guide to selecting high-performing renewable antibodies for KIF5A (Q12840) across western blot, immunoprecipitation, and immunofluorescence.

SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry.

Beyond the platelet count: A systematic review of artificial intelligence in immune thrombocytopenia.

Related Experiment Videos

Achievements in hematology in the twentieth century: an introduction

Related Concept Videos

Related Articles